Artiva Biotherapeutics, Inc. (ARTV) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

64,380,488Shares Outstanding

14,671,501Shares held by institutions

$60,299,869Value of institutional holdings

26.34%Institutional ownership %

-0.79%Shares Changed QoQ

34No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

According to SEC filings for the period ending December 2025, Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) is held by 34 institutional firms.

Institutional ownership in Artiva Biotherapeutics edged down to 26.3% in December 2025, compared to 28.1% in September 2025.
Quarterly data indicates a -0.79% shift in institutional share volume, and the annual owner count reflects a decrease of 41.38%.
Of these 34 institutional investors, 10 increased their holdings in Artiva Biotherapeutics, while 15 of them reduced positions, and 9 investors maintained their exposure.
This class of investors decreased its holdings in Artiva Biotherapeutics to 16.96Mn shares for the 13F-cycle ending December 2025, down by 134.47K shares quarter on quarter, and down 4.21Mn shares year over year.
With 9.85Mn shares, RA CAPITAL MANAGEMENT, L.P. commands the largest institutional position in Artiva Biotherapeutics as of December 31, 2025, equating to 15.30% of the company.
Among the most significant buyers of Artiva Biotherapeutics during December 2025 were Revelation Capital Management, LLC (299.31K), TWO SIGMA INVESTMENTS, LP (124.50K), VANGUARD GROUP INC (86.89K), MARSHALL WACE, LLP (79.56K), JANE STREET GROUP, LLC (40.67K).
Leading sellers of Artiva Biotherapeutics stock in December 2025 included venBio Partners LLC (500.47K), BNP PARIBAS FINANCIAL MARKETS (118.00K), BlackRock, Inc. (81.88K), MILLENNIUM MANAGEMENT LLC (45.06K), GOLDMAN SACHS GROUP INC (37.72K).
The top 10 institutional holders of Artiva Biotherapeutics for the quarter ending December 2025 included RA CAPITAL MANAGEMENT, L.P. (9.85Mn), 5AM Venture Management, LLC (2.35Mn), VR Adviser, LLC (1.61Mn), venBio Partners LLC (648.51K), FRANKLIN RESOURCES INC (520.33K), Revelation Capital Management, LLC (299.31K), VANGUARD GROUP INC (246.01K), MILLENNIUM MANAGEMENT LLC (217.10K), BlackRock, Inc. (212.54K), WELLINGTON MANAGEMENT GROUP LLP (194.11K).

34 Institutional Holders

14,671,501 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
RA CAPITAL MANAGEMENT, L.P.	31 Dec, 2025	9,853,302	0	0.00%	$42,270,666.00
5AM Venture Management, LLC	31 Dec, 2025	2,353,304	0	0.00%	$10,095,674.00
VR Adviser, LLC	31 Dec, 2025	1,609,569	0	0.00%	$6,905,051.00
venBio Partners LLC	31 Dec, 2025	648,507	-500,468	-43.56%	$2,782,095.00
FRANKLIN RESOURCES INC	31 Dec, 2025	520,327	0	0.00%	$2,232,203.00
Revelation Capital Management, LLC	31 Dec, 2025	299,311	299,311	0.00%	$1,284,044.00
VANGUARD GROUP INC	31 Dec, 2025	246,006	86,888	54.61%	$1,055,366.00
MILLENNIUM MANAGEMENT LLC	31 Dec, 2025	217,097	-45,063	-17.19%	$931,346.00
BlackRock, Inc.	31 Dec, 2025	212,538	-81,884	-27.81%	$911,788.00
WELLINGTON MANAGEMENT GROUP LLP	31 Dec, 2025	194,108	0	0.00%	$832,723.00
TWO SIGMA INVESTMENTS, LP	31 Dec, 2025	144,864	124,500	611.37%	$621,467.00
RENAISSANCE TECHNOLOGIES LLC	31 Dec, 2025	116,200	37,053	46.82%	$498,498.00
GEODE CAPITAL MANAGEMENT, LLC	31 Dec, 2025	101,117	-9,779	-8.82%	$434,132.00
Alyeska Investment Group, L.P.	31 Dec, 2025	100,000	0	0.00%	$429,000.00
MARSHALL WACE, LLP	31 Dec, 2025	79,559	79,559	0.00%	$341,308.00
JANE STREET GROUP, LLC	31 Dec, 2025	40,671	40,671	0.00%	$174,479.00
UBS Group AG	31 Dec, 2025	36,873	15,730	74.40%	$158,185.00
STATE STREET CORP	31 Dec, 2025	35,824	-24,000	-40.12%	$153,685.00
BRIDGEWAY CAPITAL MANAGEMENT, LLC	31 Dec, 2025	35,000	0	0.00%	$150,150.00
Scientech Research LLC	31 Dec, 2025	27,757	27,757	0.00%	$119,078.00

1 - 20 of 34

Research Tools